Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional Interpretation of a Novel Homozygous METTL5 Variant Associated with ADHD and Neurodevelopmental Abnormalities: A Case Report and Literature Review. | Genes (Basel) | 2025 | 41465175 | PubTator, text mining | PubMed |
| FUT2 enhances anti-tumor immunity in pancreatic cancer radiotherapy by driving FBXO2-mediated degradation of NR2F2. | Cell Death Dis | 2025 | 41436429 | PubTator, text mining | PubMed |
| METTL3 and METTL14 determine human neural fate specifications. | Nucleic Acids Res | 2025 | 41385324 | PubTator, text mining | PubMed |
| Prognostic potential of N6-methyladenosine methylation-associated genes in lung adenocarcinoma. | Transl Cancer Res | 2025 | 41378023 | PubTator, text mining | PubMed |
| Inhibition of Clostridioides difficile-Specific DNA Adenine Methyltransferase CamA by Analogs of S‑Adenosyl‑l‑methionine. | ACS Omega | 2025 | 41358085 | PubTator, text mining | PubMed |
| Circ_0060927 regulates miR-331-3p/ERK/MAPK pathway reaction in non-small cell lung cancer through METTL14-driven methylation. | Front Oncol | 2025 | 41323393 | PubTator, text mining | PubMed |
| METTL14 Regulates the Expression of Genes Related to Interferon, Interleukin and MHC Class I in Nasopharyngeal Carcinoma Cells. | Cancer Med | 2025 | 41316520 | PubTator, text mining | PubMed |
| Novel MAFG-METTL14-SCD1 axis regulates lipid metabolism mediating choroidal melanoma distant metastasis. | J Exp Clin Cancer Res | 2025 | 41316357 | PubTator, text mining | PubMed |
| Functional and clinical significance of the RNA m6A methyltransferase complex in breast cancer. | NPJ Breast Cancer | 2025 | 41310336 | PubTator, text mining | PubMed |
| Cepharanthine inhibits the proliferation and epithelial-mesenchymal transition of oral squamous cell carcinoma via HMGA2/FOXL2 axis. | BMC Pharmacol Toxicol | 2025 | 41291968 | PubTator, text mining | PubMed |
| Uncovering a role for METTL13 in malignant transformation of human hematopoietic stem cells and in the progression of pediatric leukemia. | Res Sq | 2025 | 41282185 | PubTator, text mining | PubMed |
| Impact of N6-methyladenosine (m6A) machinery on HIV-1 replication in primary CD4+ T cells. | bioRxiv | 2025 | 41278777 | PubTator, text mining | PubMed |
| Discovery of Novel Class of METTL3 Inhibitors with a Pyridin-2(1H)‑one Moiety. | ACS Med Chem Lett | 2025 | 41257017 | PubTator, text mining | PubMed |
| Regulation of m6A methylation in the immune microenvironment in the development of diabetes mellitus. | J Transl Med | 2025 | 41254647 | PubTator, text mining | PubMed |
| Discovery of CRBN-recruiting PROTAC degraders of the METTL3-METTL14 complex. | Med Chem Res | 2025 | 41245600 | PubTator, text mining | PubMed |
| The Epitranscriptomic Landscape of Gastric Cancer Stem Cells: The Emerging Role of m6A RNA Modifications. | Cancers (Basel) | 2025 | 41228380 | PubTator, text mining | PubMed |
| Mechanism of methyltransferase METTL14 mediating m6A modification and regulating SIRT5 expression to promote ferroptosis and repress gastric cancer progression. | Eur J Med Res | 2025 | 41225679 | PubTator, text mining | PubMed |
| Correction to "LncRNA UCA1 Promotes the Progression of AML by Upregulating the Expression of CXCR4 and CYP1B1 by Affecting the Stability of METTL14". | J Oncol | 2025 | 41216391 | PubTator, text mining | PubMed |
| METTL14 Mediates Malignant Progression and Docetaxel Resistance of Lung Cancer by Regulating DKK4 Expression Through m6A Methylation Modification. | J Biochem Mol Toxicol | 2025 | 41208390 | PubTator, text mining | PubMed |
| METTL14 promotes ferroptosis during the development of cisplatin-induced kidney injury by stabilizing ERFE through IGF2BP3-dependent m6A methylation. | J Trace Elem Med Biol | 2025 | 41205320 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=11